90 related articles for article (PubMed ID: 17687162)
1. The fallacy of single-agent chemotherapy for cancer.
Friedman HS; Maxwell J
J Clin Oncol; 2007 Aug; 25(23):3550; author reply 3550-1. PubMed ID: 17687162
[No Abstract] [Full Text] [Related]
2. Methylguanine methyltransferase testing in glioblastoma: when and how?
Stupp R; Hegi ME
J Clin Oncol; 2007 Apr; 25(12):1459-60. PubMed ID: 17442986
[No Abstract] [Full Text] [Related]
3. Treatment of brain tumors.
Ashby L; LaRocca R; Ryken T
N Engl J Med; 2005 Jun; 352(22):2350-3; author reply 2350-3. PubMed ID: 15938013
[No Abstract] [Full Text] [Related]
4. Treatment of brain tumors.
Seiter K
N Engl J Med; 2005 Jun; 352(22):2350-3; author reply 2350-3. PubMed ID: 15938012
[No Abstract] [Full Text] [Related]
5. Chemotherapy for brain tumors--a new beginning.
DeAngelis LM
N Engl J Med; 2005 Mar; 352(10):1036-8. PubMed ID: 15758016
[No Abstract] [Full Text] [Related]
6. Correlation between O6-methylguanine-DNA methyltransferase and survival in inoperable newly diagnosed glioblastoma patients treated with neoadjuvant temozolomide.
Chinot OL; Barrié M; Fuentes S; Eudes N; Lancelot S; Metellus P; Muracciole X; Braguer D; Ouafik L; Martin PM; Dufour H; Figarella-Branger D
J Clin Oncol; 2007 Apr; 25(12):1470-5. PubMed ID: 17442989
[TBL] [Abstract][Full Text] [Related]
7. [Temozolomide in patients with a glioblastoma multiforme: new developments].
Bromberg JE; Postma TJ
Ned Tijdschr Geneeskd; 2005 Jun; 149(25):1376-8. PubMed ID: 15997689
[TBL] [Abstract][Full Text] [Related]
8. Prognostic significance of O6-methylguanine-DNA methyltransferase protein expression in patients with recurrent glioblastoma treated with temozolomide.
Nagane M; Kobayashi K; Ohnishi A; Shimizu S; Shiokawa Y
Jpn J Clin Oncol; 2007 Dec; 37(12):897-906. PubMed ID: 18156172
[TBL] [Abstract][Full Text] [Related]
9. Long-term Results of a Survey of Prolonged Adjuvant Treatment with Temozolomide in Patients with Glioblastoma (SV3 Study).
Rivoirard R; Falk AT; Chargari C; Guy JB; Mery B; Nuti C; Peoc'h M; Forest F; Garin C; Adjabi A; Hoarau D; Kawaye S; Almokhles H; Fournel P; Magné N
Clin Oncol (R Coll Radiol); 2015 Aug; 27(8):486-7. PubMed ID: 25963856
[No Abstract] [Full Text] [Related]
10. Mechanisms of disease: temozolomide and glioblastoma--look to the future.
Mrugala MM; Chamberlain MC
Nat Clin Pract Oncol; 2008 Aug; 5(8):476-86. PubMed ID: 18542116
[TBL] [Abstract][Full Text] [Related]
11. Predictive biomarkers investigated in glioblastoma.
Tabouret E; Chinot O; Sanson M; Loundou A; Hoang-Xuan K; Delattre JY; Idbaih A
Expert Rev Mol Diagn; 2014 Sep; 14(7):883-93. PubMed ID: 25096963
[TBL] [Abstract][Full Text] [Related]
12. Temozolomide for malignant brain tumours.
Batchelor T
Lancet; 2000 Apr; 355(9210):1115-6. PubMed ID: 10791369
[No Abstract] [Full Text] [Related]
13. Synergy between methionine stress and chemotherapy in the treatment of brain tumor xenografts in athymic mice.
Kokkinakis DM; Hoffman RM; Frenkel EP; Wick JB; Han Q; Xu M; Tan Y; Schold SC
Cancer Res; 2001 May; 61(10):4017-23. PubMed ID: 11358820
[TBL] [Abstract][Full Text] [Related]
14. Antitumor activity of temozolomide combined with irinotecan is partly independent of O6-methylguanine-DNA methyltransferase and mismatch repair phenotypes in xenograft models.
Houghton PJ; Stewart CF; Cheshire PJ; Richmond LB; Kirstein MN; Poquette CA; Tan M; Friedman HS; Brent TP
Clin Cancer Res; 2000 Oct; 6(10):4110-8. PubMed ID: 11051264
[TBL] [Abstract][Full Text] [Related]
15. Chemotherapy for glioblastoma multiforme (GBM).
Roitberg B
Surg Neurol; 2006 Feb; 65(2):107-8. PubMed ID: 16427394
[No Abstract] [Full Text] [Related]
16. Solitary brain metastasis as first manifestation of small-cell parotid gland carcinoma with high sensitivity to temozolomide therapy on basis of tumor O6-methylguanine-DNA-methyltransferase expression.
Lolli I; Morra I; Cimmino A; Trevisan E; Rudà R; Piombino M; Campanella G; Gillio Tos A; De Marco L; Trevisan M; Fiano V; Soffietti R
J Clin Oncol; 2013 Aug; 31(23):e394-7. PubMed ID: 23796990
[No Abstract] [Full Text] [Related]
17. Temozolomide (Temodal) for treatment of primary brain tumours.
MacConnachie AM
Intensive Crit Care Nurs; 2000 Feb; 16(1):59-60. PubMed ID: 10790718
[TBL] [Abstract][Full Text] [Related]
18. Where does O
Weller M
Cancer; 2018 Apr; 124(7):1316-1318. PubMed ID: 29381186
[No Abstract] [Full Text] [Related]
19. [Recent advances in the medical treatment of glioma-temozolomide].
Nishikawa R
No To Shinkei; 2006 Dec; 58(12):1035-41. PubMed ID: 17193953
[No Abstract] [Full Text] [Related]
20. Down-regulation of O6-methylguanine-DNA methyl transferase enhances the effect of temozolomide in melanoma cells.
Jiang G; Zheng JN; Liu YQ
Med Hypotheses; 2011 Jan; 76(1):147-8. PubMed ID: 21044822
[No Abstract] [Full Text] [Related]
[Next] [New Search]
